BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22621932)

  • 41. Recombinant adenovirus-mediated p14(ARF) overexpression sensitizes human breast cancer cells to cisplatin.
    Deng X; Kim M; Vandier D; Jung YJ; Rikiyama T; Sgagias MK; Goldsmith M; Cowan KH
    Biochem Biophys Res Commun; 2002 Aug; 296(4):792-8. PubMed ID: 12200117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells.
    Fan G; Ma X; Wong PY; Rodrigues CM; Steer CJ
    Apoptosis; 2004 Mar; 9(2):211-21. PubMed ID: 15004518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of CCDC69 activates p14
    Cui L; Zhou F; Chen C; Wang CC
    J Ovarian Res; 2019 Jan; 12(1):4. PubMed ID: 30651135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HDM2 overexpression and focal loss of p14/ARF expression may deregulate the p53 tumour suppressor pathway in meningeal haemangiopericytomas. Study by double immunofluorescence and laser scanning confocal microscopy.
    Martínez JC; Palomino JC; Cabello A; Sepúlveda JM; de la Cámara AG; Ricoy JR
    Histopathology; 2005 Feb; 46(2):184-94. PubMed ID: 15693891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological significance of promoter hypermethylation of p14/ARF gene: relationships to p53 mutational status in Tunisian population with colorectal carcinoma.
    Chaar I; Amara S; Elamine OE; Khiari M; Ounissi D; Khalfallah T; Ben Hmida A; Mzabi S; Bouraoui S
    Tumour Biol; 2014 Feb; 35(2):1439-49. PubMed ID: 24065196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations of the p16(INK4) locus in human malignant mesothelial tumors.
    Hirao T; Bueno R; Chen CJ; Gordon GJ; Heilig E; Kelsey KT
    Carcinogenesis; 2002 Jul; 23(7):1127-30. PubMed ID: 12117769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The non-ankyrin C terminus of Ikappa Balpha physically interacts with p53 in vivo and dissociates in response to apoptotic stress, hypoxia, DNA damage, and transforming growth factor-beta 1-mediated growth suppression.
    Chang NS
    J Biol Chem; 2002 Mar; 277(12):10323-31. PubMed ID: 11799106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
    Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.
    Hasan MK; Yaguchi T; Sugihara T; Kumar PK; Taira K; Reddel RR; Kaul SC; Wadhwa R
    J Biol Chem; 2002 Oct; 277(40):37765-70. PubMed ID: 12154087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
    Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
    Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma.
    Li L; Tao Q; Jin H; van Hasselt A; Poon FF; Wang X; Zeng MS; Jia WH; Zeng YX; Chan AT; Cao Y
    Clin Cancer Res; 2010 Jun; 16(11):2949-58. PubMed ID: 20395212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p14(ARF) inhibits the functions of adenovirus E1A oncoprotein.
    Shen J; Zhang S; Li Y; Zhang W; Chen J; Zhang M; Wang T; Jiang L; Zou X; Wong J; Li X; Cui Y; Wang C
    Biochem J; 2011 Mar; 434(2):275-85. PubMed ID: 21133853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines.
    Park YB; Park MJ; Kimura K; Shimizu K; Lee SH; Yokota J
    Cancer Genet Cytogenet; 2002 Mar; 133(2):105-11. PubMed ID: 11943335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of increased levels of TGF-β1 and p14ARF in prostate carcinoma cell lines overexpressing Egr-1.
    Parra E; Gutiérrez L; Ferreira J
    Oncol Rep; 2014 Nov; 32(5):2191-8. PubMed ID: 25224321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2.
    Chang DL; Qiu W; Ying H; Zhang Y; Chen CY; Xiao ZX
    Oncogene; 2007 Jul; 26(32):4627-34. PubMed ID: 17297463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.
    Minges JT; Grossman G; Zhang P; Kafri T; Wilson EM
    J Biol Chem; 2015 Oct; 290(41):25174-87. PubMed ID: 26330556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.